---
title: "NANTIAN Information released its performance for the first three quarters, with a net loss attributable to the parent company of 10.8998 million yuan"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/261862590.md"
description: "According to the Zhitong Finance APP, NANTIAN released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 7.091 billion yuan, a year-on-year increase of 21.90%. The net loss attributable to shareholders of the listed company was 10.8998 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 20.6436 million yuan. The basic loss per share was 0.0277 yuan"
datetime: "2025-10-20T10:58:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261862590.md)
  - [en](https://longbridge.com/en/news/261862590.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261862590.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/261862590.md) | [繁體中文](https://longbridge.com/zh-HK/news/261862590.md)


# NANTIAN Information released its performance for the first three quarters, with a net loss attributable to the parent company of 10.8998 million yuan

According to the Zhitong Finance APP, NANTIAN (000948.SZ) released its third-quarter report for 2025, showing that the company's operating revenue for the first three quarters was 7.091 billion yuan, a year-on-year increase of 21.90%. The net loss attributable to shareholders of the listed company was 10.8998 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 20.6436 million yuan. The basic loss per share was 0.0277 yuan

### 相关股票

- [NANTIAN (000948.CN)](https://longbridge.com/zh-CN/quote/000948.CN.md)

## 相关资讯与研究

- [08:19 ETTata Communications Maintains a Leader Position for 13th Straight Year in Gartner® Magic Quadrant™](https://longbridge.com/zh-CN/news/281522709.md)
- [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/zh-CN/news/281325910.md)
- [CBOT Trends-Wheat down 10-12 cents, corn down 4-6 cents, soy down 7-9 cents](https://longbridge.com/zh-CN/news/281375178.md)
- [GRAINS-Corn rises for 2nd session on outlook for lower U.S. planting](https://longbridge.com/zh-CN/news/281270135.md)
- [US preparing to roll out tiered system for tariffs on steel, aluminum imports](https://longbridge.com/zh-CN/news/281552274.md)